Deeptech · Healthtech · USA
Humane Genomics
Humane Genomics
Engineering cancer-killing viruses via a synthetic-biology platform
About
Humane Genomics is a New York City company developing precision cancer therapies by engineering cancer-killing RNA/oncolytic viruses using a synthetic-biology platform. In February 2025 it announced the close of a Series Seed financing round led by Union Square Ventures. It was founded in 2016 by Peter Weijmarshausen (CEO, formerly co-founder of Shapeways) and Andrew Hessel.
Latest news
Humane Genomics Raises Seed Funding
finsmes.com2025-02
Humane Genomics - Union Square Ventures
usv.com2025-02
Checking the news desk for fresh coverage…
Coverage gathered from public sources.
Why Deeptech
Selective, conviction-led bets at the frontier - quantum, climate and next-generation digital infrastructure - where a technical edge compounds.